MEDX · NASDAQ · ETF
Horizon Kinetics Medical ETF (MEDX) Price, Holdings & Fees
Horizon Kinetics Medical ETF (MEDX) closed at $752.81 on Oct 9, 2026, up 1.33% from the previous close of $742.93.
Share price, past year
1Y +3.73%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $752.81 |
| Sep 30, 2026 | $733.50 |
| Aug 31, 2026 | $734.79 |
| Jul 31, 2026 | $702.22 |
| Jun 30, 2026 | $676.67 |
| May 29, 2026 | $668.38 |
| Apr 30, 2026 | $654.76 |
| Mar 31, 2026 | $664.55 |
| Feb 27, 2026 | $670.70 |
| Jan 30, 2026 | $659.14 |
| Dec 31, 2025 | $696.54 |
| Nov 28, 2025 | $715.94 |
| Oct 31, 2025 | $700.54 |
Key statistics
- Expense ratio
- 0.85%
- as of Apr 30, 2026
- Net assets
- $19.1M
- as of Jun 30, 2026
- Holdings
- 33
- as of Jun 30, 2026
- 52-week range
- $645.32 – $752.81
Horizon Kinetics Medical ETF's expense ratio is 0.85%: $85.00 a year on $10,000 invested.
Holdings
Horizon Kinetics Medical ETF held 33 investments worth $19.08M as of Jun 30, 2026. Its largest holding was Eli Lilly & Co, at 18.46% of the fund.
| # | Holding | % of fund | Value |
|---|---|---|---|
| 1 | Eli Lilly & CoLLY | 18.46% | $3.52M |
| 2 | US BANK MMDA - USBGFS 7 | 9.19% | $1.75M |
| 3 | AbbVie IncABBV | 8.85% | $1.69M |
| 4 | Novartis AGNVS | 6.89% | $1.31M |
| 5 | Johnson & JohnsonJNJ | 5.59% | $1.07M |
| 6 | Alkermes PLCALKS | 5.53% | $1.05M |
| 7 | AstraZeneca PLCAZN | 4.98% | $950.94K |
| 8 | Ionis Pharmaceuticals IncIONS | 4.53% | $864.58K |
| 9 | Bristol-Myers Squibb CoBMY | 4.42% | $843.79K |
| 10 | Merck & Co IncMRK | 3.96% | $754.55K |
| 11 | Amgen IncAMGN | 3.91% | $746.69K |
| 12 | Alnylam Pharmaceuticals IncALNY | 3.42% | $652.63K |
| 13 | Biogen IncBIIB | 3.09% | $588.98K |
| 14 | Pfizer IncPFE | 2.86% | $545.36K |
| 15 | GSK PLCGSK | 2.71% | $516.13K |
| 16 | CRISPR Therapeutics AGCRSP | 2.64% | $503.30K |
| 17 | Regeneron Pharmaceuticals IncREGN | 2.06% | $392.83K |
| 18 | Beam Therapeutics IncBEAM | 1.51% | $287.88K |
| 19 | Galectin Therapeutics IncGALT | 1.14% | $217.93K |
| 20 | Intellia Therapeutics IncNTLA | 1.12% | $212.92K |
| 21 | Sandoz Group AG | 0.80% | $152.02K |
| 22 | Replimune Group IncREPL | 0.73% | $139.30K |
| 23 | Vanda Pharmaceuticals IncVNDA | 0.73% | $138.61K |
| 24 | Haleon PLCHLN | 0.60% | $114.84K |
| 25 | Lantern Pharma IncLTRN | 0.55% | $104.93K |
Top 25 of 33 holdings, as of Jun 30, 2026. Percentages are of the fund's net assets.
What the fund owns
| Asset type | % of fund |
|---|---|
| Stocks | 92.64% |
| Cash and short-term investments | 9.19% |
| Country | % of fund |
|---|---|
| United States | 77.40% |
| Switzerland | 10.33% |
| United Kingdom | 8.57% |
| Ireland | 5.53% |
Shares of net assets from the fund's N-PORT report. Funds that borrow can add up to more than 100%, with borrowing (such as repurchase agreements) shown as a negative share.
Monthly total returns
Over the 3 months to Jun 30, 2026, Horizon Kinetics Medical ETF's total return was +10.12%, as reported to the SEC.
| Month | Total return |
|---|---|
| Jun 30, 2026 | +7.01% |
| May 31, 2026 | +5.00% |
| Apr 30, 2026 | −1.99% |
The fund's own total returns as reported to the SEC (N-PORT), including reinvested distributions. Not the sample prices above.
Fund profile
- Name
- Horizon Kinetics Medical ETF
- Ticker
- MEDX
- Exchange
- NASDAQ
- Fund type
- ETF
- Trust
- Listed Funds Trust
- SEC series ID
- S000078972
- SEC CIK
- 0001683471
- Fractional shares
- No
Recent SEC filings
- Aug 26, 2026
- 485BPOSProspectus updateSep 28, 2026
- 485BPOSProspectus updateSep 24, 2026
- Sep 2, 2026
- Sep 1, 2026
- 485BPOSProspectus updateAug 26, 2026
- 485BPOSProspectus updateAug 10, 2026
- Aug 6, 2026
Shareholder reports and prospectuses are filed by Listed Funds Trust, the trust behind Horizon Kinetics Medical ETF, and cover all of its funds.
Frequently asked questions
What is MEDX's price?
Horizon Kinetics Medical ETF (MEDX) closed at $752.81 on Oct 9, 2026, up 1.33% from the previous close of $742.93.
What is MEDX's expense ratio?
Horizon Kinetics Medical ETF's expense ratio is 0.85%: $85.00 a year on $10,000 invested.
What does MEDX hold?
Horizon Kinetics Medical ETF held 33 investments worth $19.08M as of Jun 30, 2026. Its largest holding was Eli Lilly & Co, at 18.46% of the fund. Its five largest holdings were Eli Lilly & Co, US BANK MMDA - USBGFS 7, AbbVie Inc, Novartis AG, Johnson & Johnson.
How has MEDX performed?
Over the 3 months to Jun 30, 2026, Horizon Kinetics Medical ETF's total return was +10.12%, as reported to the SEC.
Sources and methodology
Holdings, net assets and monthly returns come from the fund's N-PORT filing with the SEC, as of Jun 30, 2026 (filed Aug 26, 2026). The expense ratio is from the fund's prospectus or shareholder report, as of Apr 30, 2026. Prices are generated sample data for development. Data sources and disclosures